Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 349 to 356 of 356 entries
Sorted by: Best Match Show Resources per page
Antipsychotic-induced gastrointestinal hypomotility and the alteration in gut microbiota in patients with schizophrenia.

Brain, behavior, and immunity

Xu Y, Shao M, Fang X, Tang W, Zhou C, Hu X, Zhang X, Su KP.
PMID: 34563620
Brain Behav Immun. 2022 Jan;99:119-129. doi: 10.1016/j.bbi.2021.09.014. Epub 2021 Sep 24.

AIM: Gut microbiota play an important role in the pathogenesis of gut hypomotility and are critical for the production of the intestinal immune system and the maintenance of the intestinal homeostasis. Patients with psychotic disorders are at a high...

Cite
Xu Y, Shao M, Fang X, et al. Antipsychotic-induced gastrointestinal hypomotility and the alteration in gut microbiota in patients with schizophrenia. Brain Behav Immun. 2021;99:119-129doi: 10.1016/j.bbi.2021.09.014.
Xu, Y., Shao, M., Fang, X., Tang, W., Zhou, C., Hu, X., Zhang, X., & Su, K. P. (2022). Antipsychotic-induced gastrointestinal hypomotility and the alteration in gut microbiota in patients with schizophrenia. Brain, behavior, and immunity, 99119-129. https://doi.org/10.1016/j.bbi.2021.09.014
Xu, Yue, et al. "Antipsychotic-induced gastrointestinal hypomotility and the alteration in gut microbiota in patients with schizophrenia." Brain, behavior, and immunity vol. 99 (2022): 119-129. doi: https://doi.org/10.1016/j.bbi.2021.09.014
Xu Y, Shao M, Fang X, Tang W, Zhou C, Hu X, Zhang X, Su KP. Antipsychotic-induced gastrointestinal hypomotility and the alteration in gut microbiota in patients with schizophrenia. Brain Behav Immun. 2022 Jan;99:119-129. doi: 10.1016/j.bbi.2021.09.014. Epub 2021 Sep 24. PMID: 34563620.
Copy Download .nbib Format: NLM
QTc Interval Prolongation with Therapies Used to Treat Patients with Parkinson's Disease Psychosis: A Narrative Review.

Neuropsychiatric disease and treatment

Torres-Yaghi Y, Carwin A, Carolan J, Nakano S, Amjad F, Pagan F.
PMID: 34992373
Neuropsychiatr Dis Treat. 2021 Dec 24;17:3791-3818. doi: 10.2147/NDT.S324145. eCollection 2021.

In addition to the classic motor symptoms of Parkinson's disease (PD), people with PD frequently experience nonmotor symptoms that can include autonomic dysfunction and neuropsychiatric symptoms such as PD psychosis (PDP). Common patient characteristics, including older age, use of...

Cite
Torres-Yaghi Y, Carwin A, Carolan J, et al. QTc Interval Prolongation with Therapies Used to Treat Patients with Parkinson's Disease Psychosis: A Narrative Review. Neuropsychiatr Dis Treat. 2021;17:3791-3818doi: 10.2147/NDT.S324145.
Torres-Yaghi, Y., Carwin, A., Carolan, J., Nakano, S., Amjad, F., & Pagan, F. (2021). QTc Interval Prolongation with Therapies Used to Treat Patients with Parkinson's Disease Psychosis: A Narrative Review. Neuropsychiatric disease and treatment, 173791-3818. https://doi.org/10.2147/NDT.S324145
Torres-Yaghi, Yasar, et al. "QTc Interval Prolongation with Therapies Used to Treat Patients with Parkinson's Disease Psychosis: A Narrative Review." Neuropsychiatric disease and treatment vol. 17 (2021): 3791-3818. doi: https://doi.org/10.2147/NDT.S324145
Torres-Yaghi Y, Carwin A, Carolan J, Nakano S, Amjad F, Pagan F. QTc Interval Prolongation with Therapies Used to Treat Patients with Parkinson's Disease Psychosis: A Narrative Review. Neuropsychiatr Dis Treat. 2021 Dec 24;17:3791-3818. doi: 10.2147/NDT.S324145. eCollection 2021. PMID: 34992373; PMCID: PMC8714013.
Copy Download .nbib Format: NLM
Anesthetic Considerations for Patients on Psychotropic Drug Therapies.

Neurology international

Harbell MW, Dumitrascu C, Bettini L, Yu S, Thiele CM, Koyyalamudi V.
PMID: 34940748
Neurol Int. 2021 Nov 29;13(4):640-658. doi: 10.3390/neurolint13040062.

Psychotropic drugs are used in the treatment of psychiatric and non-psychiatric conditions. Many patients who are on psychotropic medications may present for procedures requiring anesthesia. Psychotropic medications can have dangerous interactions with drugs commonly used in anesthesia, some of...

Cite
Harbell MW, Dumitrascu C, Bettini L, et al. Anesthetic Considerations for Patients on Psychotropic Drug Therapies. Neurol Int. 2021;13(4):640-658doi: 10.3390/neurolint13040062.
Harbell, M. W., Dumitrascu, C., Bettini, L., Yu, S., Thiele, C. M., & Koyyalamudi, V. (2021). Anesthetic Considerations for Patients on Psychotropic Drug Therapies. Neurology international, 13(4), 640-658. https://doi.org/10.3390/neurolint13040062
Harbell, Monica W, et al. "Anesthetic Considerations for Patients on Psychotropic Drug Therapies." Neurology international vol. 13,4 (2021): 640-658. doi: https://doi.org/10.3390/neurolint13040062
Harbell MW, Dumitrascu C, Bettini L, Yu S, Thiele CM, Koyyalamudi V. Anesthetic Considerations for Patients on Psychotropic Drug Therapies. Neurol Int. 2021 Nov 29;13(4):640-658. doi: 10.3390/neurolint13040062. PMID: 34940748.
Copy Download .nbib Format: NLM
Blood-based oxidation markers in medicated and unmedicated schizophrenia patients: A meta-analysis.

Asian journal of psychiatry

Goh XX, Tang PY, Tee SF.
PMID: 34839098
Asian J Psychiatr. 2022 Jan;67:102932. doi: 10.1016/j.ajp.2021.102932. Epub 2021 Nov 21.

Increased reactive species due to the effect of antipsychotics on oxidative stress may be involved in the development of schizophrenia. However, antipsychotics may have different direct antioxidant effects due to their chemical structures. The present meta-analysis aimed to investigate...

Cite
Goh XX, Tang PY, Tee SF. Blood-based oxidation markers in medicated and unmedicated schizophrenia patients: A meta-analysis. Asian J Psychiatr. 2021;67:102932doi: 10.1016/j.ajp.2021.102932.
Goh, X. X., Tang, P. Y., & Tee, S. F. (2022). Blood-based oxidation markers in medicated and unmedicated schizophrenia patients: A meta-analysis. Asian journal of psychiatry, 67102932. https://doi.org/10.1016/j.ajp.2021.102932
Goh, Xue Xin, et al. "Blood-based oxidation markers in medicated and unmedicated schizophrenia patients: A meta-analysis." Asian journal of psychiatry vol. 67 (2022): 102932. doi: https://doi.org/10.1016/j.ajp.2021.102932
Goh XX, Tang PY, Tee SF. Blood-based oxidation markers in medicated and unmedicated schizophrenia patients: A meta-analysis. Asian J Psychiatr. 2022 Jan;67:102932. doi: 10.1016/j.ajp.2021.102932. Epub 2021 Nov 21. PMID: 34839098.
Copy Download .nbib Format: NLM
Head-to-head comparison of various antipsychotic agents on genome-wide methylation in schizophrenia.

Pharmacogenomics

Adanty C, Shakeri A, Strauss J, Graff A, De Luca V.
PMID: 34787483
Pharmacogenomics. 2022 Jan;23(1):5-14. doi: 10.2217/pgs-2021-0113. Epub 2021 Nov 17.

No abstract available.

Cite
Adanty C, Shakeri A, Strauss J, et al. Head-to-head comparison of various antipsychotic agents on genome-wide methylation in schizophrenia. Pharmacogenomics. 2021;23(1):5-14doi: 10.2217/pgs-2021-0113.
Adanty, C., Shakeri, A., Strauss, J., Graff, A., & De Luca, V. (2022). Head-to-head comparison of various antipsychotic agents on genome-wide methylation in schizophrenia. Pharmacogenomics, 23(1), 5-14. https://doi.org/10.2217/pgs-2021-0113
Adanty, Christopher, et al. "Head-to-head comparison of various antipsychotic agents on genome-wide methylation in schizophrenia." Pharmacogenomics vol. 23,1 (2022): 5-14. doi: https://doi.org/10.2217/pgs-2021-0113
Adanty C, Shakeri A, Strauss J, Graff A, De Luca V. Head-to-head comparison of various antipsychotic agents on genome-wide methylation in schizophrenia. Pharmacogenomics. 2022 Jan;23(1):5-14. doi: 10.2217/pgs-2021-0113. Epub 2021 Nov 17. PMID: 34787483.
Copy Download .nbib Format: NLM
Clinically Relevant Interactions between Atypical Antipsychotics and Anti-Infective Agents.

Pharmaceuticals (Basel, Switzerland)

Spina E, Barbieri MA, Cicala G, de Leon J.
PMID: 33276675
Pharmaceuticals (Basel). 2020 Dec 02;13(12). doi: 10.3390/ph13120439.

This is a comprehensive review of the literature on drug interactions (DIs) between atypical antipsychotics and anti-infective agents that focuses on those DIs with the potential to be clinically relevant and classifies them as pharmacokinetic (PK) or pharmacodynamic (PD)...

Cite
Spina E, Barbieri MA, Cicala G, et al. Clinically Relevant Interactions between Atypical Antipsychotics and Anti-Infective Agents. Pharmaceuticals (Basel). 2020;13(12)doi: 10.3390/ph13120439.
Spina, E., Barbieri, M. A., Cicala, G., & de Leon, J. (2020). Clinically Relevant Interactions between Atypical Antipsychotics and Anti-Infective Agents. Pharmaceuticals (Basel, Switzerland), 13(12), . https://doi.org/10.3390/ph13120439
Spina, Edoardo, et al. "Clinically Relevant Interactions between Atypical Antipsychotics and Anti-Infective Agents." Pharmaceuticals (Basel, Switzerland) vol. 13,12 (2020). doi: https://doi.org/10.3390/ph13120439
Spina E, Barbieri MA, Cicala G, de Leon J. Clinically Relevant Interactions between Atypical Antipsychotics and Anti-Infective Agents. Pharmaceuticals (Basel). 2020 Dec 02;13(12). doi: 10.3390/ph13120439. PMID: 33276675; PMCID: PMC7761579.
Copy Download .nbib Format: NLM
Effect of Varenicline on Tardive Dyskinesia: A Pilot Study.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology

Caroff SN, Gutman AR, Northrop J, Leong SH, Berkowitz RM, Campbell EC.
PMID: 33888664
Clin Psychopharmacol Neurosci. 2021 May 31;19(2):355-360. doi: 10.9758/cpn.2021.19.2.355.

OBJECTIVE: Although evidence implicates striatal cholinergic impairment as a mechanism underlying tardive dyskinesia, trials of nonspecific cholinergic agents have been inconclusive. As a partial agonist at specific nicotinic receptor subtypes, varenicline reduces drug-induced dyskinesias in animal models suggesting promise...

Cite
Caroff SN, Gutman AR, Northrop J, et al. Effect of Varenicline on Tardive Dyskinesia: A Pilot Study. Clin Psychopharmacol Neurosci. 2021;19(2):355-360doi: 10.9758/cpn.2021.19.2.355.
Caroff, S. N., Gutman, A. R., Northrop, J., Leong, S. H., Berkowitz, R. M., & Campbell, E. C. (2021). Effect of Varenicline on Tardive Dyskinesia: A Pilot Study. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 19(2), 355-360. https://doi.org/10.9758/cpn.2021.19.2.355
Caroff, Stanley N, et al. "Effect of Varenicline on Tardive Dyskinesia: A Pilot Study." Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology vol. 19,2 (2021): 355-360. doi: https://doi.org/10.9758/cpn.2021.19.2.355
Caroff SN, Gutman AR, Northrop J, Leong SH, Berkowitz RM, Campbell EC. Effect of Varenicline on Tardive Dyskinesia: A Pilot Study. Clin Psychopharmacol Neurosci. 2021 May 31;19(2):355-360. doi: 10.9758/cpn.2021.19.2.355. PMID: 33888664; PMCID: PMC8077061.
Copy Download .nbib Format: NLM
Paliperidone to Treat Psychotic Disorders.

Neurology international

Minwalla HD, Wrzesinski P, Desforges A, Caskey J, Wagner B, Ingraffia P, Patterson JC, Edinoff AN, Kaye AM, Kaye AD, Viswanath O, Urits I.
PMID: 34449689
Neurol Int. 2021 Jul 28;13(3):343-358. doi: 10.3390/neurolint13030035.

PURPOSE OF REVIEW: This is a comprehensive review of the literature regarding the use of paliperidone in the treatment of schizophrenia and schizoaffective disorder. It covers the background and presentation of schizophrenia and schizoaffective disorder, as well as the...

Cite
Minwalla HD, Wrzesinski P, Desforges A, et al. Paliperidone to Treat Psychotic Disorders. Neurol Int. 2021;13(3):343-358doi: 10.3390/neurolint13030035.
Minwalla, H. D., Wrzesinski, P., Desforges, A., Caskey, J., Wagner, B., Ingraffia, P., Patterson, J. C., Edinoff, A. N., Kaye, A. M., Kaye, A. D., Viswanath, O., & Urits, I. (2021). Paliperidone to Treat Psychotic Disorders. Neurology international, 13(3), 343-358. https://doi.org/10.3390/neurolint13030035
Minwalla, Hormazd D, et al. "Paliperidone to Treat Psychotic Disorders." Neurology international vol. 13,3 (2021): 343-358. doi: https://doi.org/10.3390/neurolint13030035
Minwalla HD, Wrzesinski P, Desforges A, Caskey J, Wagner B, Ingraffia P, Patterson JC, Edinoff AN, Kaye AM, Kaye AD, Viswanath O, Urits I. Paliperidone to Treat Psychotic Disorders. Neurol Int. 2021 Jul 28;13(3):343-358. doi: 10.3390/neurolint13030035. PMID: 34449689; PMCID: PMC8396046.
Copy Download .nbib Format: NLM
Showing 349 to 356 of 356 entries